Stock listing

OCC Stock Price, News, Filings & Events — Orthocell Ltd

Selected listing: OCC · ASX · AUD · AU

This page tracks Orthocell Ltd's OCC:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following OCC:ASX. OCC:ASX is the stock-level entry point for investors researching Orthocell Ltd, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Orthocell Ltd (Ticker: OCC) is a public company based in Australia, focusing on innovative regenerative medicine solutions. With a market capitalization of approximately AUD 141.88 million, Orthocell is dedicated to developing advanced therapies for tissue repair and regeneration. The company's commitment to research and development aims to improve patient outcomes in various medical fields.

OCC:ASXAUDAUUpdated September 11, 2026
Orthocell Ltd logo
Ticker
OCC:ASX
Asset type
Stock
Market cap
$141.2M
Sector
Health Technology
Industry
Medical Specialties
Exchange
ASX
Currency
AUD

Orthocell Ltd OCC:ASX stock context

This page tracks Orthocell Ltd's OCC:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following OCC:ASX. OCC:ASX is the stock-level entry point for investors researching Orthocell Ltd, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Orthocell Ltd (Ticker: OCC) is a public company based in Australia, focusing on innovative regenerative medicine solutions. With a market capitalization of approximately AUD 141.88 million, Orthocell is dedicated to developing advanced therapies for tissue repair and regeneration. The company's commitment to research and development aims to improve patient outcomes in various medical fields.

Latest news from Orthocell Ltd

All Orthocell Ltd news →

Research Orthocell Ltd

Alternate listings